Lite Strategy’s Covered Calls Yield $0.7M, Repurchase 1.63M Shares
Lite Strategy’s covered call program generated $0.7 million in net proceeds since October 2025, and the company used 35,250 LTC and those proceeds to repurchase 1,629,136 shares through March 31, 2026. The company advanced pre-clinical pharmaceutical programs for non-oncology indications and noted SEC guidance classifying Litecoin as a digital commodity.
1. Quarter Financial Highlights
For the fiscal third quarter ended March 31, 2026, Lite Strategy’s covered call option program generated $0.7 million in net proceeds since its October 2025 launch. The company deployed 35,250 LTC along with option proceeds to repurchase 1,629,136 shares, reflecting disciplined capital allocation and efforts to narrow the discount to NAV.
2. Pharmaceutical Operations
During the quarter, Lite Strategy continued advancement of its pre-clinical development programs in non-oncology disease indications. These programs represent potential sources of non-dilutive capital through out-licensing or asset sales, offering strategic optionality beyond cryptocurrency treasury management.
3. Regulatory Clarity on Litecoin
In March 2026, the SEC released guidance affirming Litecoin’s status as a digital commodity, providing greater clarity on its regulatory classification. This development enhances institutional confidence in LTC exposure for corporate treasuries and asset managers.
4. Strategic Outlook
Looking ahead, Lite Strategy plans to scale its covered call options program and deploy up to $25 million under its share repurchase authorization. The company is also evaluating strategic investments and partnerships to drive broader Litecoin adoption and deepen institutional engagement with the LTC ecosystem.